Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Carmen Vigo-Pelfrey"'
Autor:
John H. Growdon, Roger M. Nitsch, Dale Schenk, Robert D. Moir, Christoph Hock, Werner Naser, Sidonie Golombowski, Konrad Beyreuther, Franz Müller-Spahn, Rudolph E. Tanzi, Ursula Mönning, Carmen Vigo-Pelfrey, Ashley M. Bush
Publikováno v:
European Neurology. 39:111-118
Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by progressive dementia that ultimately leads to death. Histopathological hallmarks of AD include brain amyloid deposits and neurofibrillary tangles. Major depressio
Autor:
Hans Basun, Ivan Lieberburg, Lars Lannfelt, Lars-Olof Wahlund, Carmen Vigo-Pelfrey, Bengt Winblad, Dale Schenk
Publikováno v:
Neuroscience Letters. 199:203-206
The neuropathological hallmarks of Alzheimer's disease (AD) are amyloid-containing plaques and neurofibrillary tangles. The main constituent of senile plaques is amyloid β-peptide (Aβ) and in recent years, pathogenic mutations in the amyloid precur
Autor:
Janet A. Johnston, Christine Miller, Dennis J. Selkoe, Bengt Winblad, David B. Teplow, Dale Schenk, Lars Lannfelt, Nikolaos Venizelos, Carmen Vigo-Pelfrey, Martin Citron
Publikováno v:
Proceedings of the National Academy of Sciences. 91:11993-11997
The 39- to 43-amino acid amyloid beta-protein (A beta), which is progressively deposited in cerebral plaques and blood vessels in Alzheimer disease (AD), is secreted by cultured human cells during normal metabolism. In studies of cell lines transfect
Publikováno v:
Journal of Neurochemistry. 61:1965-1968
β-Amyloid peptide (Aβ) is one of the main components of senile plaques in the brain tissue of Alzheimer's disease (AD) patients. Aβ is proteolytically cleaved from the amyloid precursor protein (APP), an integral membrane protein possessing a larg
Autor:
Albert Y. Hung, Edward H. Koo, Beth L. Ostaszewski, A Mellon, Michael G. Schlossmacher, Ivan Lieberburg, Carmen Vigo-Pelfrey, Dale B. Schenk, Christian Haass, David B. Teplow
Publikováno v:
Nature. 359:322-325
Alzheimer's disease is characterized by the extracellular deposition in the brain and its blood vessels of insoluble aggregates of the amyloid beta-peptide (A beta), a fragment, of about 40 amino acids in length, of the integral membrane protein beta
Publikováno v:
Chemistry and Physics of Lipids. 53:91-101
Partially hydrogenated egg phosphatidylcholines (PHEPC) represent a new class of raw materials for liposome-based drug products. PHEPC were manufactured from native egge phosphatidylcholine (EPC) to iodine values (IV) 40, 30, 20, 10, and 1. Hydrogena
Autor:
Dennis J. Selkoe, Peter Seubert, Tilman Oltersdorf, Christian Haass, Ivan Lieberburg, Martin Citron, Lisa C. Mcconlogue, Albert Y. Hung, Carmen Vigo-Pelfrey
Publikováno v:
Nature. 360:672-674
Progressive cerebral deposition of the 39-43-amino-acid amyloid beta-protein (A beta) is an invariant feature of Alzheimer's disease which precedes symptoms of dementia by years or decades. The only specific molecular defects that cause Alzheimer's d
Autor:
Justine Whaley, Peter Seubert, Dennis J. Selkoe, Carmen Vigo-Pelfrey, Harry F. Dovey, Robert L. Wolfert, Robert T. McCormack, Sukanto Sinha, Dale Schenk, Cathy Swindlehurst, Frederick Esch, Michael Schiossmacher, Michael K. Lee, Dave Davis, Ivan Lieberburg
Publikováno v:
Nature. 359:325-327
CEREBRAL deposition of the β-amyloid peptide (Aβ) is an invariant feature of Alzheimer's disease. Since the original isola-tion and characterization of αβ (ref. 1) and the subsequent cloning of its precursor protein2–5, no direct evidence for t
Autor:
Timothy C. Kasunic, Joel B. Kirkpatrick, Mark R. Emmerling, Geoffrey Murdoch, Carmen Vigo-Pelfrey, Yu Min Kuo, Melvyn J. Ball, Alex E. Roher
Publikováno v:
The Journal of biological chemistry. 271(8)
Ultracentrifugation and graded molecular sieving, as well as a sensitive sandwich enzyme-linked immunosorbent assay were used to isolate and quantitate the amounts of water-soluble oligomers of beta amyloid (Abeta) peptides N-40 and N-42 in cerebral
Autor:
Peter Seubert, R. Wolfert, Kelly Johnson-Wood, R. Motter, Linda Chang, Dale Schenk, D. Olson, C. Clark, Carmen Vigo-Pelfrey, Bruce L. Miller, Doug R. Galasko, P. Southwick, Robin Barbour, B. Munroe, Robert C. Green, Dora Kholodenko, Ivan Lieberburg
Publikováno v:
Annals of neurology. 38(4)
In this clinical study the cerebrospinal fluid (CSF) level of a novel form of the beta-amyloid peptide (A beta) extending to position 42 (A beta 42) was determined in patients with Alzheimer's disease (AD) as well as controls. In addition to measurem